GENF vs. OKYO, SAR, SNG, AOR, AREC, IMM, OPTI, RLM, NSCI, and HEMO
Should you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include OKYO Pharma (OKYO), Sareum (SAR), Synairgen (SNG), AorTech International (AOR), Arecor Therapeutics (AREC), ImmuPharma (IMM), OptiBiotix Health (OPTI), Realm Therapeutics (RLM), NetScientific (NSCI), and Hemogenyx Pharmaceuticals (HEMO). These companies are all part of the "biotechnology" industry.
Genflow Biosciences vs.
Genflow Biosciences (LON:GENF) and OKYO Pharma (LON:OKYO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, community ranking, valuation, earnings, risk, dividends, profitability and analyst recommendations.
9.2% of Genflow Biosciences shares are owned by institutional investors. 64.2% of Genflow Biosciences shares are owned by insiders. Comparatively, 31.9% of OKYO Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
OKYO Pharma received 7 more outperform votes than Genflow Biosciences when rated by MarketBeat users.
In the previous week, Genflow Biosciences' average media sentiment score of 0.00 equaled OKYO Pharma'saverage media sentiment score.
Genflow Biosciences has a net margin of 778.46% compared to OKYO Pharma's net margin of 0.00%. Genflow Biosciences' return on equity of -208.12% beat OKYO Pharma's return on equity.
Genflow Biosciences has a beta of 2.37, suggesting that its stock price is 137% more volatile than the S&P 500. Comparatively, OKYO Pharma has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500.
Genflow Biosciences has higher earnings, but lower revenue than OKYO Pharma. Genflow Biosciences is trading at a lower price-to-earnings ratio than OKYO Pharma, indicating that it is currently the more affordable of the two stocks.
Summary
Genflow Biosciences beats OKYO Pharma on 8 of the 11 factors compared between the two stocks.
Get Genflow Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genflow Biosciences Competitors List
Related Companies and Tools
This page (LON:GENF) was last updated on 2/23/2025 by MarketBeat.com Staff
Free GENF Stock Alerts